Pilar Manrique, senior scientist at Microviable Therapeutics will be present at 9th Microbiome Microbiome Movement Summit taking place in Barcelona in January 28-30th 2025!
The Summit explored the latest advances in microbiome science, where innovative biotechs were uncovering new microbial targets, deciphering mechanisms of action and harnessing state-of-the-art analytical tools to uncover the microbiome’s role in disease. Attendees engaged with investors and C-level leaders as our producers strategised how to bring big pharma back into the fold of emerging microbial modalities.
Pilar will provide a lecture on day 28 to showcase the lates data on our microbiota-derived biological drug MVT-201. Pilar will present the latest data of the product and application into infectious diseases, including efficacy results on a murine model of VRE. She will go deep on the mechanism of action and the latest advancements towards the clinic. Moreover, Pilar will introduce our drug development platform, PharmaBiota, that has recently enabled Microviable to develop new products.
Last but not least, on Tuesday 30th, Pilar will join other experts on the panel discussion entitled: Unravelling Complex Technologies in Microbiome Analysis.
If you want to get in touch with us you can do it on the following email: info@microviable.com
